Quinolynylmethylimidizoles as therapeutic agents

Details Quinolynylmethylimidizoles as therapeutic agents Quinolynylmethylimidizoles as therapeutic agents

A - Human Necessities

61

K

A61K 31/4709 (2006.01) A61P 27/06 (2006.01)

Patent

CA 2724293

Disclosed herein are methods for treating a disorder associated with selective subtype modulation of alpha 2B and alpha 2C adrenergic receptors. Such methods can be performed, for example, by administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of at least one compound having the structure (I). Compositions and medicaments related thereto are also disclosed.

Méthodes pour le traitement d'un trouble associé à une modulation de sous-type sélective des récepteurs adrénergiques alpha 2B et alpha 2C. De telles méthodes peuvent être réalisées, par exemple, par administration d'une composition pharmaceutique contenant une quantité efficace thérapeutiquement d'au moins un composé possédant la structure (I) à un patient le nécessitant. L'invention concerne des compositions et des médicaments associés à celles-ci.

Affiliated with

Also associated with

Rating

Quinolynylmethylimidizoles as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinolynylmethylimidizoles as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolynylmethylimidizoles as therapeutic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1844821